Inspire Medical Systems (INSP) EBITDA (2017 - 2026)

Inspire Medical Systems has disclosed EBITDA across 10 years of filings, most recently posting -$1.1 million for Q1 2026.

• EBITDA for Q1 2026 came in at -$1.1 million, down 141.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $141.5 million (up 112.51% YoY), and the FY2025 annual result was $145.4 million, up 172.98% from the prior year.
• EBITDA came in at -$1.1 million for Q1 2026 at Inspire Medical Systems, down from $135.9 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $135.9 million in Q4 2025 to a low of -$17.0 million in Q3 2022.
• The 5-year median for EBITDA is -$1.1 million (2026), against an average of $7.8 million.
• Across the five-year window, EBITDA jumped 352.85% in 2023 and sank 141.67% in 2026, its largest moves.
• Inspire Medical Systems' EBITDA stood at $3.4 million in 2022, then soared by 352.85% to $15.5 million in 2023, then surged by 119.47% to $34.1 million in 2024, then jumped by 299.05% to $135.9 million in 2025, then sank by 100.82% to -$1.1 million in 2026.
• The last three EBITDA figures came in at -$1.1 million (Q1 2026), $135.9 million (Q4 2025), and $10.2 million (Q3 2025), per Business Quant data.